Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis

Infection. 2020 Oct;48(5):805-806. doi: 10.1007/s15010-020-01441-4. Epub 2020 May 10.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections*
  • Glucocorticoids
  • Humans
  • Immunoglobulins
  • Myocarditis*
  • Pandemics*
  • Pneumonia, Viral*
  • SARS-CoV-2

Substances

  • Glucocorticoids
  • Immunoglobulins